Clinical and Pathological Studies in the Oldest Old
Clinical and Pathological Studies in the Oldest Old
批准号:
7496763
负责人:
CLAUDIA H. KAWAS
金额:
$20.39万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2008-02-29
关键词:
Activities of Daily LivingAgeAge-YearsAged, 80 and overAgingAllelesAlzheimer&aposs DiseaseAmericanAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApolipoprotein EAscorbic AcidBrainCerebrumCessation of lifeCharacteristicsCholesterolClinicalCognitionCognitiveCohort StudiesCommitConditionDataDementiaDietDiseaseDropsDrug usageEnvironmental Risk FactorEpidemiologyExerciseFamily history ofFolateFrequenciesGeneticGenotypeGoalsHabitsHealthHomocysteineHomocystineIbuprofenImpaired cognitionIncidenceIndividualInjuryIntakeInvestigationLifeLife StyleLipidsLongevityLower ExtremityMeasuresMedical HistoryNeurofibrillary TanglesNumbersNutrientOxidative StressPathologyPerformancePharmaceutical PreparationsPopulationPrevalenceProteinsRangeRateReportingRiskRisk FactorsSampling StudiesSerum Folate LevelSocietiesVitaminsagedaging braincognitive functioncohortexperiencefallsfollow-upfunctional declinemembermortalityneuroinflammationnormal agingprospectivesocial
中文摘要
高龄老人的临床与病理研究
在接下来的20年里,美国90岁及以上的老年人数量将翻一番,达到300多万人。
因为以前的研究很少有,如果有的话,超过90岁的受试者,对这些先驱者或对他们的研究知之甚少。
与成功老龄化和健康相关的因素。
这项计划的目的是调查与极端老年相关的临床,遗传和病理因素。
我们回顾了1981年发起的休闲世界队列研究的调查。20多年来,
成员(N= 13,979)提供了病史和生活方式信息,包括疾病状况、家族史、
病史、运动、社会活动和药物使用,如抗氧化剂和非甾体抗炎药
(NSAIDS)。
我们的中心假设是大脑中的氧化损伤和炎症导致衰老、疾病和死亡,
摄入抗氧化剂和非甾体类抗炎药将减缓认知能力的下降,改善老年人的健康。
我们的具体目标是:(1)在4,682名达到年龄的队列成员中检查与长寿相关的因素
90人与6734人相比,(2)确定1,644人中痴呆的患病率,发病率和危险因素
生活在他们的第十和第十一个十年的队列成员,(3)进行纵向随访,以衡量率
认知和功能下降,这些最古老的老年人,(4)完成我们的调查与临床
健康和疾病中脑老化的病理相关性,重点是脑功能指标的相关性,
氧化损伤、炎症标志物、斑块和缠结病理学,因为它与临床状态和既往使用有关
of antioxidant抗氧化剂and anti-inflammatory抗炎compounds化合物.
休闲世界队列研究为遗传和环境的研究提供了一个独特的人口样本
与长寿和高龄老人成功老龄化相关的因素。有一大批致力于
受试者和20年的前瞻性数据,我们提出的调查可以大大有助于了解
认知,功能能力和大脑病理学在我们社会中最古老的成员。
英文摘要
CLINICAL ANDPATHOLOGICAL STUDIES IN THE OLDEST OLD
In the next two decades, the numberof Americans aged 90 years and older will nearly double to over 3 million people.
Because previous studies have few, if any, subjects over 90 years of age, little is known about these pioneers or about
factors associated with successful aging and health in this group.
The goals of this proposal are to investigate clinical,genetic, and pathological factors associated with extreme old age.
We superimpose our investigations on the Leisure World Cohort Study, initiated in 1981. For over 20 years, cohort
members (N=13,979) have provided medical history and lifestyle information including morbid conditions, family
history, exercise, social activities, and medication use such as antioxidants and non-steroidal anti-inflammatorydrugs
(NSAIDS).
Our central hypothesis is that oxidative damage and inflammationin the brain results in aging, disease and death and
that intake of antioxidants and NSAIDS will slow cognitive decline and improvethe health of the oldest old.
Our Specific Aims are: (1) to examine factors associated with longevity in the 4,682 cohort members who reached age
90 compared to the 6734 who did not, (2) to determine the prevalence, incidence, and risk factors for dementia in 1,644
living cohort members in their tenth and eleventh decades, (3) to conduct longitudinal follow-up to measure rates of
cognitive and functional decline in these oldest old subjects, and (4) to complete our investigations with clinical
pathological correlates of brain aging in health and disease, focusing on the association of cerebral measures of
oxidative injury, inflammatorymarkers, and plaqueand tangle pathology as it relates to clinical status and previous use
of antioxidant and anti-inflammatorycompounds.
The Leisure World Cohort Study provides a unique population sample for the study of genetic and environmental
factors associated with longevity and successful aging in the oldest old. With a substantial cohort of committed
subjects and 20 years of prospective data, our proposed investigations can contribute much to the understanding of
cognition, functional abilities, and cerebral pathology in the oldest members of our society.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B-Clinical Core
-
批准号:9922101
-
项目类别:
-
资助金额:$61.75万
-
财政年份:2020
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
-
批准号:8166929
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2009
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
-
批准号:7951079
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2008
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
CORE--CLINICAL
-
批准号:6932809
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2005
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6578726
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:8230622
-
项目类别:
-
资助金额:$136.92万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7463369
-
项目类别:
-
资助金额:$134.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6907727
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Education and information transfer
-
批准号:6578728
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6934497
-
项目类别:
-
资助金额:$119.18万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6659008
-
项目类别:
-
资助金额:$104.62万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6782570
-
项目类别:
-
资助金额:$119.2万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6507991
-
项目类别:
-
资助金额:$109.34万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7575781
-
项目类别:
-
资助金额:$134.86万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:8039091
-
项目类别:
-
资助金额:$135.73万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7112272
-
项目类别:
-
资助金额:$118.38万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7796652
-
项目类别:
-
资助金额:$138.21万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Education and information transfer
-
批准号:6448161
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2001
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6448159
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2001
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6299255
-
项目类别:
-
资助金额:$24.78万
-
财政年份:2000
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: